01—Abstract
Summary
Summary of the 8-K filed March 11, 2025. Cited figures are marked; the original filing is the authoritative source.
Amcor plc (NYSE/ASX: AMCR) announced on March 11, 2025 that the waiting period under the U.S. Hart-Scott-Rodino (HSR) Act expired on March 10, 2025 for its pending merger with Berry Global Group (NYSE: BERY).
Under the Agreement and Plan of Merger signed November 19, 2024, a wholly-owned Amcor subsidiary will merge into Berry, with Berry surviving as a wholly-owned subsidiary of Amcor. Clearing the HSR waiting period is a significant milestone, as it satisfies one of the key closing conditions, and the companies also disclosed that additional approvals, including antitrust clearances from China and Brazil, have been received in recent weeks. The companies still need to satisfy remaining regulatory approvals and other customary closing conditions, and they reiterated their expectation that the transaction will close in the middle of calendar year 2025.
The filing contains no new financial terms, synergy figures, or updated guidance, so investors should look to the original merger announcement and the joint proxy statement/prospectus (effective January 23, 2025) for valuation and synergy detail. For investors, the filing is a positive procedural update that reduces deal-closing risk, but completion still depends on the remaining approvals and closing conditions. The forward-looking statements caution that risks such as integration challenges, failure to realize anticipated synergies, litigation, and increased indebtedness could affect outcomes.
02—Key points
Key Highlights
- HSR Act waiting period expired on March 10, 2025, satisfying one of the necessary closing conditions for the Amcor-Berry merger.
- Additional regulatory clearances received in recent weeks, including antitrust approvals from China and Brazil.
- Amcor and Berry continue to expect the transaction to close in the middle of calendar year 2025.
- Merger structure: Amcor subsidiary Aurora Spirit, Inc. merges into Berry, which becomes a wholly-owned Amcor subsidiary.
- Remaining closing conditions include other regulatory approvals and customary conditions; progress is described as 'well advanced.'
- The filing discloses no new deal economics, synergy estimates, or financial guidance changes.
- Joint proxy statement/prospectus was declared effective by the SEC on January 23, 2025.
03—Questions
Frequently Asked Questions
What does the HSR waiting period expiration mean for the deal?
The expiration of the waiting period under the HSR Act means U.S. antitrust authorities did not block or extend review of the merger within the statutory timeframe, removing one of the key conditions to closing. Other closing conditions, including remaining regulatory approvals, still need to be satisfied.
When is the Amcor-Berry merger expected to close?
Amcor and Berry expect the merger to close in the middle of calendar year 2025, subject to satisfaction or waiver of the remaining closing conditions.
What will happen to Berry Global after the merger?
Under the Merger Agreement, Berry will survive the merger as a wholly-owned subsidiary of Amcor, and its shares will no longer trade independently once the transaction closes.
Does this filing change the financial terms of the deal?
No. The 8-K only reports the HSR clearance and related approvals. It does not disclose changes to the consideration, synergy targets, or financial guidance, so investors should refer to the original merger agreement and joint proxy statement/prospectus.
What risks could still prevent the deal from closing?
Risks include failure to satisfy remaining regulatory approvals or closing conditions in a timely manner, integration challenges, the possibility that anticipated benefits are not realized, litigation, business disruption during pendency, and increased indebtedness or credit rating pressure, as described in the cautionary statement.
04—Continue